SUPERFICIAL INFLAMMATORY DERMATOSIS

This adverse event was reported 123 times

These drugs are most commonly taken by patients reporting SUPERFICIAL INFLAMMATORY DERMATOSIS:

# Drug Count
0 ADALIMUMAB 12
1 ADALIMUMAB-AATY 10
2 ADALIMUMAB-ADAZ 10
3 ADALIMUMAB-FKJP 10
4 PREDNISONE 7
5 METHOTREXATE 6
6 METHOTREXATE SODIUM 6
7 PACLITAXEL 6
8 ASPIRIN 5
9 ASPIRIN 325 MG 5
See all common drugs associated with SUPERFICIAL INFLAMMATORY DERMATOSIS

SUPERFICIAL INFLAMMATORY DERMATOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ALITRETINOIN 2 0.0168
1 HYPOCHLOROUS ACID 1 0.0093
2 ALBENDAZOLE 3 0.0016
3 CETYLPYRIDINIUM CHLORIDE 1 0.0015
4 BRODALUMAB 2 0.0010
5 TERBINAFINE TABLETS 250 MG 1 0.0008
6 SALICYLIC ACID 12% 1 0.0005
7 ASTRINGENT 1 0.0005
8 LIQUID CORN AND CALLUS REMOVER 1 0.0005
9 CEFADROXIL 1 0.0005
See all drugs enriched for association with SUPERFICIAL INFLAMMATORY DERMATOSIS